105 related articles for article (PubMed ID: 27599808)
1. Lung caught in Nilutamide treatment.
Lourenço EP; Nzwalo H; Sampaio MR; Brito H
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27599808
[No Abstract] [Full Text] [Related]
2. Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Jun; 159(6):2099. PubMed ID: 9598539
[No Abstract] [Full Text] [Related]
3. Nilutamide-induced neutropenia.
Eaton VS; Blackmore TK
BJU Int; 2001 Nov; 88(7):801-2. PubMed ID: 11890258
[No Abstract] [Full Text] [Related]
4. Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.
Gomez JL; Dupont A; Cusan L; Tremblay M; Tremblay M; Labrie F
Am J Med; 1992 May; 92(5):563-6. PubMed ID: 1580304
[TBL] [Abstract][Full Text] [Related]
5. Delayed dark adaptation caused by nilutamide.
Chan P; Odel JG
J Neuroophthalmol; 2008 Jun; 28(2):158-9. PubMed ID: 18562852
[No Abstract] [Full Text] [Related]
6. Watchful waiting beats androgen deprivation therapy in early prostate cancer.
Brower V
J Natl Cancer Inst; 2008 Nov; 100(21):1494-6. PubMed ID: 18957680
[No Abstract] [Full Text] [Related]
7. Pulmonary complications of hormone treatment in prostate carcinoma.
Seigneur J; Trechot PF; Hubert J; Lamy P
Chest; 1988 May; 93(5):1106. PubMed ID: 3129240
[TBL] [Abstract][Full Text] [Related]
8. Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
McCaffrey JA; Scher HI
J Urol; 1998 Jul; 160(1):131. PubMed ID: 9628626
[No Abstract] [Full Text] [Related]
9. [Fatal fulminant hepatitis induced by nilutamide (Anandron)].
Pescatore P; Hammel P; Durand F; Bertheau P; Bernuau J; Huc D; Gerbal JL; Degott C; Benhamou JP
Gastroenterol Clin Biol; 1993; 17(6-7):499-501. PubMed ID: 8243938
[TBL] [Abstract][Full Text] [Related]
10. Long-term side-effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study.
Malone S; Perry G; Segal R; Dahrouge S; Crook J
BJU Int; 2005 Sep; 96(4):514-20. PubMed ID: 16104902
[TBL] [Abstract][Full Text] [Related]
11. Fulminant hepatic failure due to nilutamide hepatotoxicity.
Merwat SN; Kabbani W; Adler DG
Dig Dis Sci; 2009 Apr; 54(4):910-3. PubMed ID: 18688719
[No Abstract] [Full Text] [Related]
12. I'm on androgen deprivation therapy (ADT) for prostate cancer. I've heard that it may cause heart problems. Should I be worried?
Johns Hopkins Med Lett Health After 50; 2010 May; 22(3):8. PubMed ID: 20518140
[No Abstract] [Full Text] [Related]
13. [Clinical study of RU 23908 (nilutamide) in prostatic cancer].
Akaza H; Aso Y; Niijima T; Fuse H; Izaka S; Akimoto S; Shimazaki J; Imai K; Yamanaka H; Kihara K
Hinyokika Kiyo; 1991 Apr; 37(4):407-20. PubMed ID: 1892002
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of nilutamide.
Gaillard-Moguilewsky M; de Gery A; Ulmann A
Cancer; 1993 Dec; 72(12 Suppl):3828-9. PubMed ID: 8252498
[No Abstract] [Full Text] [Related]
15. Does prophylactic breast irradiation in patients with prostate cancer influence cardiac toxicity?
Nieder C; Pawinski A; Andratschke NH; Molls M
J Natl Cancer Inst; 2007 Nov; 99(21):1646-7. PubMed ID: 17971531
[No Abstract] [Full Text] [Related]
16. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.
Kassouf W; Tanguay S; Aprikian AG
J Urol; 2003 May; 169(5):1742-4. PubMed ID: 12686822
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
Nakabayashi M; Regan MM; Lifsey D; Kantoff PW; Taplin ME; Sartor O; Oh WK
BJU Int; 2005 Oct; 96(6):783-6. PubMed ID: 16153200
[TBL] [Abstract][Full Text] [Related]
18. [Fatal interstitial lung disease associated with maximum androgen blockade].
Molina Mancero G; Picón X; Di Tullio F; Ernst G; Dezanzo P; Salvado A; Chertcoff JF
Rev Med Chil; 2016 Oct; 144(10):1356-1359. PubMed ID: 28074993
[TBL] [Abstract][Full Text] [Related]
19. Nilutamide: an antiandrogen for the treatment of prostate cancer.
Dole EJ; Holdsworth MT
Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
[TBL] [Abstract][Full Text] [Related]
20. Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.
Boccardo F; Decensi AU; Guarneri D; Martorana G; Fioretto L; Mini E; Macaluso MP; Giuliani L; Santi L; Periti P
Cancer Detect Prev; 1991; 15(6):501-3. PubMed ID: 1782640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
